What is Hunan Nucien Pharmaceutical Co Days Payable?
Hunan Nucien Pharmaceutical CoSHSE:688189 +1.90%52 Days Payable is 132.50 as of Mar. 2026, which is 4% above its 10-year median of 127.10. GuruFocus rates SHSE:688189 with a GF Score™ of 52/100 and a GF Value™ of ¥2.36 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 922 Drug Manufacturers companies, Hunan Nucien Pharmaceutical Co ranks worse than 51.3% on this metric.
The historical rank and industry rank for Hunan Nucien Pharmaceutical Co's Days Payable or its related term are showing as below:
SHSE:688189'
s Days Payable Range Over the Past 10 Years
Min: 61.9 Med: 127.1 Max: 356.41
Current: 88.47
During the past 10 years, Hunan Nucien Pharmaceutical Co's highest Days Payable was 356.41. The lowest was 61.90. And the median was 127.10.
SHSE:688189's Days Payable is ranked worse than 51.3% of 922
companies
in the Drug Manufacturers industry
Industry Median: 90.455
vs SHSE:688189: 88.47
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Nucien Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hunan Nucien Pharmaceutical Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hunan Nucien Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Hunan Nucien Pharmaceutical Co's Days Payable falls into.
Hunan Nucien Pharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hunan Nucien Pharmaceutical Co (SHSE:688189) has a Days Payable of 132.50 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hunan Nucien Pharmaceutical Co and its competitors. This is near median its historical median of 127.10. Over the past decade, Hunan Nucien Pharmaceutical Co's Days Payable has ranged from 61.90 to 356.41. According to the industry distribution chart, Hunan Nucien Pharmaceutical Co ranks #473 out of 922 companies in the Drug Manufacturers industry, placing it in the top 51.3%.
Is Hunan Nucien Pharmaceutical Co's Days Payable too high?
Hunan Nucien Pharmaceutical Co's current Days Payable of 132.50 is near median its 10-year median of 127.10. Over the past 10 years, this metric has ranged from a low of 61.90 to a high of 356.41. The Drug Manufacturers industry median Days Payable is 90.46. Hunan Nucien Pharmaceutical Co's value of 132.50 is 46.5% above this industry median. Based on the distribution chart, Hunan Nucien Pharmaceutical Co ranks #473 out of 922 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Hunan Nucien Pharmaceutical Co has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hunan Nucien Pharmaceutical Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hunan Nucien Pharmaceutical Co ranks #473 out of 922 companies for Days Payable. This places Hunan Nucien Pharmaceutical Co in the lower half of its industry. The industry median Days Payable is 90.46. Hunan Nucien Pharmaceutical Co's value of 132.50 is 46.5% above this benchmark. Historically, Hunan Nucien Pharmaceutical Co's own Days Payable has ranged from 61.90 to 356.41 over the past decade. While the company's 10-year median is 127.10 vs. the industry median of 90.46, Hunan Nucien Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.46, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hunan Nucien Pharmaceutical Co's current Days Payable of 132.50 is 46.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hunan Nucien Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hunan Nucien Pharmaceutical Co's current Days Payable is 132.50, which is near median its own 10-year median of 127.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hunan Nucien Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hunan Nucien Pharmaceutical Co (SHSE:688189) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥2.36, compared to a current price of ¥6.42 — trading 172% above its estimated fair value. The current Days Payable is 132.50, which is near median its 10-year median of 127.10 and 46.5% above the Drug Manufacturers industry median of 90.46. Hunan Nucien Pharmaceutical Co's overall GF Score™ is 52/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Hunan Nucien Pharmaceutical Co (SHSE:688189), the current Days Payable is 132.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hunan Nucien Pharmaceutical Co (SHSE:688189) Overvalued in 2026?
Based on GuruFocus' analysis, Hunan Nucien Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥6.42 is trading 172% above its estimated GF Value™ of ¥2.36.
GuruFocus considers Hunan Nucien Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for SHSE:688189:
Days Payable: 132.50 (near median its 10-year median of 127.10)
GF Value™: ¥2.36 vs. price of ¥6.42 (172% above fair value)
Industry Position: 46.5% above the Drug Manufacturers median (#473 of 922)
No single metric tells the full story. See the SHSE:688189 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hunan Nucien Pharmaceutical Co Business Description
Hunan Nucien Pharmaceutical Co Ltd is a pharmaceutical company integrating drug research and development, production and sales. The company focuses on anti-infection, cardio-cerebral vascular, anti-tumor and other pharmaceutical fields. The company's business scope includes the manufacturing and sales of chemical pharmaceutical preparations, chemical pharmaceutical raw materials, biological drugs, chemical reagents, and auxiliaries.
52GF Score
Get the complete analysis for SHSE:688189
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688189 has been successfully added to your 
